GPT Healthcare to go public to fund expansion
The company operates four mid-sized hospitals with a total bed capacity of 556 in eastern India
The company operates four mid-sized hospitals with a total bed capacity of 556 in eastern India
The BiCNU brand and generic market had U.S. sales of approximately US $ 19.4 million MAT for the most recent twelve months ending in August 2021, according to IQVIA Health
Emkay Research expects Q2FY22 to be a normalised quarter for pharma companies that it tracks. A summary of the report
It has planned an investment of over Rs 80 crore in the next five years
Since its inception, the company has either acquired or taken a majority stake in five companies
Conventional Itraconazole mainstay drug to fight fungal infection has high result variance and low patient compliance because of dosing dependence upon food, acidic beverage and antacid consumption
It is one of the first companies to launch a bioequivalent version of the dry powder inhaler and it's part of the company’s strategic exclusive in-licensing arrangement to market Tiotropium DPI in Western Europe and the UK
The first study to investigate the safety and immunogenicity of both vaccines when co-administered compared to each vaccine administered separately in adults aged 65 years and older
The agreement will sharpen Cigna's focus on the growth path for its rapidly expanding global health portfolio
In Q2FY22, growth from Covid-driven products in the domestic branded formulation sales should dissipate on a QoQ basis as new covid cases have declined sharply. Vishal Manchanda, research analyst Nirmal Bang gives a preview of pharma companies in this report
Subscribe To Our Newsletter & Stay Updated